• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry.

作者信息

Locatelli F, Conte F, Marcelli D

出版信息

Nephrol Dial Transplant. 1998 Jul;13(7):1642-4. doi: 10.1093/ndt/13.7.1642.

DOI:10.1093/ndt/13.7.1642
PMID:9681705
Abstract
摘要

相似文献

1
The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry.血细胞比容水平和促红细胞生成素治疗对总体及心血管死亡率和发病率的影响——伦巴第透析登记处的经验
Nephrol Dial Transplant. 1998 Jul;13(7):1642-4. doi: 10.1093/ndt/13.7.1642.
2
[A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].血细胞比容大于36可降低血液透析患者的死亡率和住院率。
Nefrologia. 2003;23(2):177-8.
3
Target haematocrit during erythropoietin treatment in dialysis patients. Which value is 'true-functional haematocrit'?
Nephrol Dial Transplant. 1999 May;14(5):1340-1. doi: 10.1093/ndt/14.5.1340.
4
Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.促红细胞生成素治疗终末期肾病合并糖尿病的贫血
Diabetes Care. 1990 Nov;13(11):1130-1. doi: 10.2337/diacare.13.11.1130b.
5
Defining a renal anemia management period.定义肾性贫血管理期。
Am J Kidney Dis. 2000 Dec;36(6 Suppl 3):S13-23. doi: 10.1053/ajkd.2000.19927.
6
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.达比加群酯与促红细胞生成素α在开始血液透析的终末期肾病患者中的长期疗效比较：一项准实验队列研究。
Am J Kidney Dis. 2015 Jul;66(1):106-13. doi: 10.1053/j.ajkd.2015.02.339. Epub 2015 May 2.
7
Erythropoietin 1997: a brief update.促红细胞生成素1997：简要更新
Perit Dial Int. 1997;17 Suppl 2:S84-90.
8
Effect of erythropoietin on cardiovascular diseases.促红细胞生成素对心血管疾病的影响。
Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S20-5. doi: 10.1053/ajkd.2001.27391.
9
Anemia management in patients with chronic renal insufficiency.慢性肾功能不全患者的贫血管理
Am J Kidney Dis. 2000 Dec;36(6 Suppl 3):S39-51. doi: 10.1053/ajkd.2000.19930.
10
Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy.
Lancet. 1988 Jan 16;1(8577):97-100. doi: 10.1016/s0140-6736(88)90293-0.

引用本文的文献

1
Endogenous Sex Steroid Hormones, Sex Hormone-Binding Globulin, and Risk of All-Cause and Cause-Specific Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.内源性性激素、性激素结合球蛋白与全因及特定病因死亡率风险：前瞻性队列研究的系统评价与剂量反应荟萃分析
J Clin Endocrinol Metab. 2025 Aug 7;110(9):e3131-e3149. doi: 10.1210/clinem/dgaf262.
2
Hemoglobin and Clinical Outcomes in Hemodialysis: An Analysis of US Medicare Data From 2018 to 2020.血液透析中的血红蛋白与临床结局：对2018年至2020年美国医疗保险数据的分析
Kidney Med. 2022 Dec 7;5(2):100578. doi: 10.1016/j.xkme.2022.100578. eCollection 2023 Feb.
3
Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism.
西那卡塞在慢性肾脏病继发性甲状旁腺功能亢进患者中的应用与心血管事件、骨折和死亡风险的关系。
Sci Rep. 2018 Feb 1;8(1):2103. doi: 10.1038/s41598-018-20552-5.
4
Comparison of Methods Study between a Photonic Crystal Biosensor and Certified ELISA to Measure Biomarkers of Iron Deficiency in Chronic Kidney Disease Patients.比较光子晶体生物传感器和认证 ELISA 方法在测量慢性肾脏病患者缺铁生物标志物中的应用。
Sensors (Basel). 2017 Sep 25;17(10):2203. doi: 10.3390/s17102203.
5
The effect of Vitamin D administration on treatment of anemia in end-stage renal disease patients with Vitamin D deficiency on hemodialysis: A placebo-controlled, double-blind clinical trial.维生素D给药对血液透析的维生素D缺乏终末期肾病患者贫血治疗的影响：一项安慰剂对照、双盲临床试验。
J Res Med Sci. 2015 Aug;20(8):745-50. doi: 10.4103/1735-1995.168375.
6
Anaemia predicts cardiovascular events in patients with stable coronary artery disease.贫血可预测稳定型冠状动脉疾病患者的心血管事件。
Neth Heart J. 2005 Aug;13(7-8):254-258.
7
Potential cardiovascular risk protection of bilirubin in end-stage renal disease patients under hemodialysis.血液透析末期肾病患者中胆红素对心血管风险的潜在保护作用
Biomed Res Int. 2014;2014:175286. doi: 10.1155/2014/175286. Epub 2014 Sep 10.
8
Decisive indicator for gastrointestinal workup in anemic patients with nondialysis chronic kidney disease.非透析慢性肾脏病伴贫血患者胃肠检查的决定性指标。
Int J Med Sci. 2012;9(8):634-41. doi: 10.7150/ijms.4969. Epub 2012 Sep 19.
9
Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?我们是否应该重新考虑基于当前铁蛋白和血红素浓度的铁剂治疗？
Clin Exp Nephrol. 2012 Dec;16(6):819-26. doi: 10.1007/s10157-012-0694-3. Epub 2012 Sep 29.
10
Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat.重组人促红细胞生成素对大鼠慢性肾衰竭中期的心脏抗凋亡和促增殖作用
J Pharm Bioallied Sci. 2012 Jan;4(1):76-83. doi: 10.4103/0975-7406.92743.